CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma...
Phase 1
Montréal, Quebec, Canada and 2 other locations
TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...
Phase 2
Montreal, Quebec, Canada and 47 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Montreal, Quebec, Canada and 215 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Montreal, Quebec, Canada and 82 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Montréal, Quebec, Canada and 93 other locations
The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...
Phase 3
Montreal, Quebec, Canada and 34 other locations
in adult participants with Relapsed or Refractory Non-Hodgkin's Lymphoma (R/R NHL).The study will be conducted in 2 parts: Part A, monothera...
Phase 1
Montreal, Quebec, Canada and 12 other locations
This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...
Phase 3
Montréal, Quebec, Canada and 119 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Montréal, Canada and 140 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Montreal, Quebec, Canada and 37 other locations
Clinical trials
Research sites
Resources
Legal